- You are here: Home
- Disease Models
- Inflammation & Autoimmune Disease Models
- Delayed-Type Hypersensitivity (DTH) Models
Disease Models
- Oncology Models
-
Inflammation & Autoimmune Disease Models
- Rheumatoid Arthritis Models
- Glomerulonephritis Models
- Multiple Sclerosis (MS) Models
- Ocular Inflammation Models
- Sjögren's Syndrome Model
- LPS-induced Acute Lung Injury Model
- Peritonitis Models
- Passive Cutaneous Anaphylaxis Model
- Delayed-Type Hypersensitivity (DTH) Models
- Inflammatory Bowel Disease Models
- Systemic Lupus Erythematosus Animal Models
- Asthma Model
- Sepsis Model
- Psoriasis Model
- Atopic Dermatitis (AD) Model
- Scleroderma Model
- Gouty Arthritis Model
- Carrageenan-Induced Air Pouch Synovitis Model
- Carrageenan-Induced Paw Edema Model
- Experimental Autoimmune Myasthenia Gravis (EAMG) Model
- Cardiovascular Disease Models
-
Neurological Disease Models
- Alzheimer's Disease Modeling and Assays
- Seizure Models
- Parkinson's Disease Models
- Ischemic Stroke Models
- Acute Spinal Cord Injury (ASCI) Model
- Traumatic Brain Injury (TBI) Model
- Hypoxic-Ischemic Encephalopathy (HIE) Model
- Tourette Syndrome (TS) Model
- Amyotrophic Lateral Sclerosis (ALS) Model
- Huntington's Disease (HD) Model
- Intracerebral hemorrhage (ICH) Models
- Pain Models
- Metabolic Disease Models
- Liver Disease Models
- Rare Disease Models
- Respiratory Disease Models
- Digestive Disease Models
-
Urology Disease Models
- Cisplatin-induced Nephrotoxicity Model
- Unilateral Ureteral Obstruction Model
- 5/6 Nephrectomy Model
- Renal Ischemia-Reperfusion Injury (RIRI) Model
- Diabetic Nephropathy (DN) Models
- Passive Heymann Nephritis (PHN) Model
- Adenine-Induced Chronic Kidney Disease (CKD) Model
- Kidney Stone Model
- Doxorubicin-Induced Nephropathy Model
- Orthopedic Disease Models
- Ocular Disease Models
Delayed-Type Hypersensitivity (DTH) Models
Delayed-type hypersensitivity (DTH) is a useful model for assessing cell-mediated immune responses related to Th1 and Th17 reactivity. The delayed-type hypersensitivity reaction is mainly mediated by CD4+ or CD8+ T lymphocytes and consist of sensitization phase and challenge phase. The delayed-type hypersensitivity response is typically tested within 48 h after initial application.
Creative Bioarray, with a prestigious team in the industry, focuses on providing customized experiment services to help customers evaluate novel therapeutic interventions against DTH and study the basic mechanisms of DTH.
Delayed-type hypersensitivity (DTH) models include but not limited to:
- keyhole limpet hemocyanin (KLH)-induced DTH model
- oxazolone (OX)-induced DTH model
Our capabilities
- We measure the differences in paw swelling and weight of mice after different treatments within 48 h post exposure.
- We evaluate the impact of drug candidates on myeloperoxidase (MPO) activity and cytokine concentrations by Elisa assay.
Assays available
- PK/PD blood collections
- Histopathological evaluation
- Cytokine analysis
- Flow cytometry analysis
With extensive experience in the field of DTH, we are confident to help you to overcome any upcoming challenges. Our experts are fully capable of customizing our protocols and assays to meet your specific needs. With our help, we wish to facilitate your research with high efficiency.
Study examples
Figure. 1. Histopathological evaluation of cellular infiltrates in the ears from KLH induced mice treated with BIRB-796.
Figure. 2. Oxazolone (OX)-induced DTH in K14-VEGF-A-tg mice differentially alters tissue cytokines, lymphatic drainage and DC migration at the DAY 2 and DAY 9 time point.
Quotation and ordering
If you have any special needs or questions regarding our services, please feel free to contact us. We look forward to cooperating with you in the future.
References
- Aebischer D, Willrodt A H, Halin C. Oxazolone-Induced Contact Hypersensitivity Reduces Lymphatic Drainage but Enhances the Induction of Adaptive Immunity[J]. PLOS ONE, 2014, 9.
- Engstrom L, et al. Characterization of a murine keyhole limpet hemocyanin (KLH)-delayed-type hypersensitivity (DTH) model: Role for p38 kinase[J]. International Immunopharmacology, 2009, 9(10):0-1227.
For research use only. Not for any other purpose.
